[SCHERING-PLOUGH LOGO] News Release
Schering-Plough Corporation
2000 Galloping Hill Road
Kenilworth, New Jersey 07033-0530
- --------------------------------------------------------------------------------
For Release: IMMEDIATELY Contact: Robert J. Consalvo
(908) 298-7409
SCHERING-PLOUGH ANNOUNCES PRICING OF SENIOR NOTES OFFERING
----------------------------------------------------------
AND INCREASE IN OFFERING TO $2.4 BILLION
----------------------------------------
KENILWORTH, N.J., Nov. 21, 2003 - Schering-Plough Corporation (NYSE: SGP) today
announced that it has agreed to sell $1.25 billion aggregate principal amount
of 5.3% senior notes due 2013 and $1.15 billion aggregate principal amount of
6.5% senior notes due 2033 through an underwritten registered public offering.
The senior notes are rated A3 with a stable outlook by Moody's, A+ on
CreditWatch with negative implications by Standard and Poor's and A- with a
negative outlook by Fitch. The offering is expected to close on November 26,
2003, subject to customary closing conditions.
Merrill Lynch & Co. and Citigroup are acting as the joint book-running
managers for the offering and may be contacted at 212-449-4916 and
212-723-6171, respectively.
This announcement is neither an offer to sell nor the solicitation of
an offer to buy the senior notes or any other securities and shall not
constitute an offer, solicitation or sale, nor shall there be any sale, in any
jurisdiction in which such offer, solicitation or sale is unlawful.
DISCLOSURE NOTICE: This release contains forward-looking statements
about Schering-Plough's intention to raise funds from the sale of senior notes
which statements are indicated by the words "will," "plan," "expect" and
similar expressions. Such forward-looking statements are subject to risks and
uncertainties. Readers are cautioned not to place undue reliance on such
statements, which speak only as of the date on which they are made. The
company undertakes no obligation to update or revise such forward-looking
statements. For a discussion of risks and uncertainties that may cause actual
results to vary from forward looking statements, see Schering-Plough's filings
with the Securities and Exchange Commission, including the third quarter 2003
10-Q filed November 7, 2003.
Schering-Plough is a research-based company engaged in the discovery,
development, manufacturing and marketing of pharmaceutical products worldwide.
# # #